· Volume surge · GH

Guardant Health Inc (GH) climbs 13.2% as turnover expands

The precision-oncology diagnostics stock extended a strong 12-week run, with heavy weekly activity supporting the move.

Diagnostics laboratory equipment and market data screen representing Guardant Health market activity.

Guardant Health Inc (GH) closed at 149.22 USD for the week ended June 26, rising 13.2% in weekly market data. The move lifted its four-week gain to 15.1% and its twelve-week advance to 59.0%.

Confirmation was broad but not unqualified. Turnover reached 28.6 million shares, about 2.3 times the 13-week average, while the trend signal remained active and Market Dynamics showed positive pressure at 1.12. Relative Strength at 49.2 was more neutral, keeping the momentum profile from looking one-sided in the weekly price path over 52 weeks.